InvestorsHub Logo
icon url

MinnieM

09/15/17 4:04 PM

#197073 RE: scottsmith #197066

Finding it in a slide didn't bother me at all. Clinical trials are fluid. It's impossible to do anything more than simply estimate the timelines. Trials regularly take longer than expected. And, the timing didn't really matter to me since I'm not trading on the interim results. My only concern is for the final trial results since that will dictate whether or not we get a partner for Prurisol.






In Reply to 'scottsmith'
Yep. Remember how we found out that the interim was moved back from q2 to q3? Thrown into a slide in small print during that first CC. I personally found that disconcerting and have viewed things a bit more suspiciously since.





icon url

MinnieM

09/15/17 9:57 PM

#197105 RE: scottsmith #197066

Completed ph2b is next upcoming event for Prurisol. Prurisol interim is missing from upcoming milestones in 2017. Surprising most of us missed it since last change came out on a presentation slide.

See slide 20 from BioCentury presentation:



Full slide deck:

https://static1.squarespace.com/static/5715352e20c647639137f992/t/59b2f34946c3c498ebfe112e/1504899917915/IPIX+Company+Presentation+BioCentury+NewsMakers+Conference++8Sep2017.pdf





In Reply to 'scottsmith'
Yep. Remember how we found out that the interim was moved back from q2 to q3? Thrown into a slide in small print during that first CC. I personally found that disconcerting and have viewed things a bit more suspiciously since.